M6229
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for M6229, covering 2025-02-11 to 2025-12-16. Get the full timeline:
Most recent: Clinical Trial Update: A Study in Healthy Subjects to Assess the Safety and Tolerability of a 120-hour Continuous Infusion of M6229 [Phase 1]